Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Dental erosion in schoolchildren and associated factors: A cross-sectional study.

Frazao JB, Machado LG, Ferreira MC.

J Indian Soc Pedod Prev Dent. 2018 Apr-Jun;36(2):113-119. doi: 10.4103/JISPPD.JISPPD_1041_17.

2.

Old and new calcimimetics for treatment of secondary hyperparathyroidism: impact on biochemical and relevant clinical outcomes.

Pereira L, Meng C, Marques D, Frazão JM.

Clin Kidney J. 2018 Feb;11(1):80-88. doi: 10.1093/ckj/sfx125. Epub 2017 Dec 8.

3.

Dietary magnesium supplementation prevents and reverses vascular and soft tissue calcifications in uremic rats.

Diaz-Tocados JM, Peralta-Ramirez A, Rodríguez-Ortiz ME, Raya AI, Lopez I, Pineda C, Herencia C, Montes de Oca A, Vergara N, Steppan S, Pendon-Ruiz de Mier MV, Buendía P, Carmona A, Carracedo J, Alcalá-Díaz JF, Frazao J, Martínez-Moreno JM, Canalejo A, Felsenfeld A, Rodriguez M, Aguilera-Tejero E, Almadén Y, Muñoz-Castañeda JR.

Kidney Int. 2017 Nov;92(5):1084-1099. doi: 10.1016/j.kint.2017.04.011. Epub 2017 Jul 29.

PMID:
28760336
4.

Higher mineralized bone volume is associated with a lower plain X-Ray vascular calcification score in hemodialysis patients.

Adragao T, Ferreira A, Frazao JM, Papoila AL, Pinto I, Monier-Faugere MC, Malluche HH.

PLoS One. 2017 Jul 7;12(7):e0179868. doi: 10.1371/journal.pone.0179868. eCollection 2017.

5.

The performance of probiotic fermented sheep milk and ice cream sheep milk in inhibiting enamel mineral loss.

Nadelman P, Frazão JV, Vieira TI, Balthazar CF, Andrade MM, Alexandria AK, Cruz AG, Fonseca-Gonçalves A, Maia LC.

Food Res Int. 2017 Jul;97:184-190. doi: 10.1016/j.foodres.2017.03.051. Epub 2017 Apr 3.

PMID:
28578040
6.

Parathyroidectomy in Persistent Post-transplantation Hyperparathyroidism - Single-center Experience.

Meng C, Martins P, Frazão J, Pestana M.

Transplant Proc. 2017 May;49(4):795-798. doi: 10.1016/j.transproceed.2017.01.067.

PMID:
28457397
7.

Cortical bone analysis in a predialysis population: a comparison with a dialysis population.

Carvalho C, Magalhães J, Neto R, Pereira L, Branco P, Adragão T, Frazão JM.

J Bone Miner Metab. 2016 Nov 9. [Epub ahead of print]

PMID:
27830383
8.

The role of bone biopsy for the diagnosis of renal osteodystrophy: a short overview and future perspectives.

Carvalho C, Alves CM, Frazão JM.

J Nephrol. 2016 Oct;29(5):617-26. doi: 10.1007/s40620-016-0339-9. Epub 2016 Jul 29. Review.

PMID:
27473148
9.

Validating silicon polytrodes with paired juxtacellular recordings: method and dataset.

Neto JP, Lopes G, Frazão J, Nogueira J, Lacerda P, Baião P, Aarts A, Andrei A, Musa S, Fortunato E, Barquinha P, Kampff AR.

J Neurophysiol. 2016 Aug 1;116(2):892-903. doi: 10.1152/jn.00103.2016. Epub 2016 Jun 15.

10.

Primary immunodeficiency association with systemic lupus erythematosus: review of literature and lessons learned by the Rheumatology Division of a tertiary university hospital at São Paulo, Brazil.

Errante PR, Perazzio SF, Frazão JB, da Silva NP, Andrade LE.

Rev Bras Reumatol Engl Ed. 2016 Jan-Feb;56(1):58-68. doi: 10.1016/j.rbre.2015.07.006. Epub 2015 Sep 1. English, Portuguese.

11.

Blueprint for a European calciphylaxis registry initiative: the European Calciphylaxis Network (EuCalNet).

Brandenburg V, Adragao T, van Dam B, Evenepoel P, Frazão JM, Ketteler M, Mazzaferro S, Urena Torres P, Ramos R, Torregrosa JV, Cozzolino M.

Clin Kidney J. 2015 Oct;8(5):567-71. doi: 10.1093/ckj/sfv056. Epub 2015 Jul 6. Review.

12.

Evolution of bone disease after kidney transplantation: A prospective histomorphometric analysis of trabecular and cortical bone.

Carvalho C, Magalhães J, Pereira L, Simões-Silva L, Castro-Ferreira I, Frazão JM.

Nephrology (Carlton). 2016 Jan;21(1):55-61. doi: 10.1111/nep.12570.

PMID:
26201946
13.

Bonsai: an event-based framework for processing and controlling data streams.

Lopes G, Bonacchi N, Frazão J, Neto JP, Atallah BV, Soares S, Moreira L, Matias S, Itskov PM, Correia PA, Medina RE, Calcaterra L, Dreosti E, Paton JJ, Kampff AR.

Front Neuroinform. 2015 Apr 8;9:7. doi: 10.3389/fninf.2015.00007. eCollection 2015.

14.

Calciphylaxis: from the disease to the diseased.

Oliveira TM, Frazão JM.

J Nephrol. 2015 Oct;28(5):531-40. doi: 10.1007/s40620-015-0192-2. Epub 2015 Apr 3. Review.

PMID:
25835730
15.

Nutrition and dietary intake and their association with mortality and hospitalisation in adults with chronic kidney disease treated with haemodialysis: protocol for DIET-HD, a prospective multinational cohort study.

Palmer SC, Ruospo M, Campbell KL, Garcia Larsen V, Saglimbene V, Natale P, Gargano L, Craig JC, Johnson DW, Tonelli M, Knight J, Bednarek-Skublewska A, Celia E, Del Castillo D, Dulawa J, Ecder T, Fabricius E, Frazão JM, Gelfman R, Hoischen SH, Schön S, Stroumza P, Timofte D, Török M, Hegbrant J, Wollheim C, Frantzen L, Strippoli GF; DIET-HD Study investigators.

BMJ Open. 2015 Mar 20;5(3):e006897. doi: 10.1136/bmjopen-2014-006897.

16.

Regulation of CYBB Gene Expression in Human Phagocytes by a Distant Upstream NF-κB Binding Site.

Frazão JB, Thain A, Zhu Z, Luengo M, Condino-Neto A, Newburger PE.

J Cell Biochem. 2015 Sep;116(9):2008-17. doi: 10.1002/jcb.25155.

17.

The role of fibroblast growth factor 23 in chronic kidney disease-mineral and bone disorder.

Diniz H, Frazão JM.

Nefrologia. 2013 Nov 13;33(6):835-44. doi: 10.3265/Nefrologia.pre2013.Jul.12091. Epub 2013 Oct 25. Review.

18.

Toll-like receptors' pathway disturbances are associated with increased susceptibility to infections in humans.

Frazão JB, Errante PR, Condino-Neto A.

Arch Immunol Ther Exp (Warsz). 2013 Dec;61(6):427-43. doi: 10.1007/s00005-013-0243-0. Epub 2013 Sep 22. Review.

PMID:
24057516
19.

HOX antisense lincRNA HOXA-AS2 is an apoptosis repressor in all trans retinoic acid treated NB4 promyelocytic leukemia cells.

Zhao H, Zhang X, Frazão JB, Condino-Neto A, Newburger PE.

J Cell Biochem. 2013 Oct;114(10):2375-83. doi: 10.1002/jcb.24586.

20.

Is serum phosphorus control related to parathyroid hormone control in dialysis patients with secondary hyperparathyroidism?

Frazão JM, Braun J, Messa P, Dehmel B, Mattin C, Wilkie M.

BMC Nephrol. 2012 Aug 3;13:76. doi: 10.1186/1471-2369-13-76.

21.

Non-calcium-containing phosphate binders: comparing efficacy, safety, and other clinical effects.

Frazão JM, Adragão T.

Nephron Clin Pract. 2012;120(2):c108-19. doi: 10.1159/000337087. Epub 2012 Apr 28. Review.

22.

High-performance liquid chromatography under partially denaturing conditions (dHPLC) is a fast and cost-effective method for screening molecular defects: four novel mutations found in X-linked chronic granulomatous disease.

de Oliveira-Junior EB, Prando C, Lopez JA, Arango JC, Buzolin M, Rehder J, Pedroza LA, Frazão JB, Dantas VM, Roxo-Junior P, Grumach AS, Costa-Carvalho BT, Bustamante J, Condino-Neto A.

Scand J Immunol. 2012 Aug;76(2):158-66. doi: 10.1111/j.1365-3083.2012.02714.x.

23.

Cinacalcet reduces plasma intact parathyroid hormone, serum phosphate and calcium levels in patients with secondary hyperparathyroidism irrespective of its severity.

Frazão JM, Messa P, Mellotte GJ, Geiger H, Hagen EC, Quarles LD, Kerr PG, Baños A, Dehmel B, Urena P.

Clin Nephrol. 2011 Sep;76(3):233-43.

PMID:
21888861
24.

Mother to child transfer of IgG and IgA antibodies against Dermatophagoides pteronyssinus.

Macchiaverni P, Arslanian C, Frazão JB, Palmeira P, Russo M, Verhasselt V, Condino-Neto A.

Scand J Immunol. 2011 Dec;74(6):619-27. doi: 10.1111/j.1365-3083.2011.02615.x.

25.

[Primary amyloidosis associated with kappa light chain myeloma].

Martins RG, Roncon-Albuquerque R Jr, Cabral R, Frazão J, Von Hafe P.

Acta Med Port. 2010 Mar-Apr;23(2):281-4. Epub 2010 Apr 14. Portuguese.

26.

Therapeutic implications of heparin-induced thrombocytopenia complicating acute hemodialysis.

Roncon-Albuquerque R Jr, Beco A, Ferreira AL, Gomes-Carvalho C, Costa A, Frazão J, Pestana M, von Hafe P.

Clin Nephrol. 2010 Apr;73(4):326-30.

PMID:
20353743
27.

Femoral bone mineral density reflects histologically determined cortical bone volume in hemodialysis patients.

Adragao T, Herberth J, Monier-Faugere MC, Branscum AJ, Ferreira A, Frazao JM, Malluche HH.

Osteoporos Int. 2010 Apr;21(4):619-25. doi: 10.1007/s00198-009-0988-9. Epub 2009 Jun 25.

28.

Adynamic bone disease: clinical and therapeutic implications.

Frazão JM, Martins P.

Curr Opin Nephrol Hypertens. 2009 Jul;18(4):303-7. doi: 10.1097/MNH.0b013e32832c4df0. Review.

PMID:
19424062
29.

Impact of vitamin D dose on biochemical parameters in patients with secondary hyperparathyroidism receiving cinacalcet.

Wilkie M, Pontoriero G, Macário F, Yaqoob M, Bouman K, Braun J, von Albertini B, Brink H, Maduell F, Graf H, Frazão JM, Bos WJ, Torregrosa V, Saha H, Reichel H, Zani VJ, Carter D, Messa P.

Nephron Clin Pract. 2009;112(1):c41-50. doi: 10.1159/000212102. Epub 2009 Apr 10.

PMID:
19365139
30.

Low bone volume--a risk factor for coronary calcifications in hemodialysis patients.

Adragao T, Herberth J, Monier-Faugere MC, Branscum AJ, Ferreira A, Frazao JM, Dias Curto J, Malluche HH.

Clin J Am Soc Nephrol. 2009 Feb;4(2):450-5. doi: 10.2215/CJN.01870408. Epub 2009 Jan 21.

31.
32.

Cardiovascular risk in dialysis patients: an X-ray vision on vascular calcifications.

Adragão T, Frazão JM.

Kidney Int. 2008 Dec;74(12):1505-7. doi: 10.1038/ki.2008.503.

33.

The use of interferon-gamma therapy in chronic granulomatous disease.

Errante PR, Frazão JB, Condino-Neto A.

Recent Pat Antiinfect Drug Discov. 2008 Nov;3(3):225-30. Review.

PMID:
18991804
34.

Syzygium jambolanum treatment improves survival in lethal sepsis induced in mice.

Maciel MC, Farias JC, Maluf MJ, Gomes EA, Pereira PV, Aragão-Filho WC, Frazão JB, Costa GC, Sousa SM, Silva LA, Amaral FM, Russo M, Guerra RN, Nascimento FR.

BMC Complement Altern Med. 2008 Oct 13;8:57. doi: 10.1186/1472-6882-8-57.

35.

Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA Council.

Covic A, Cannata-Andia J, Cancarini G, Coppo R, Frazão JM, Goldsmith D, Ronco P, Spasovski GB, Stenvinkel P, Utas C, Wiecek A, Zoccali C, London G.

Nephrol Dial Transplant. 2008 Dec;23(12):3731-7. doi: 10.1093/ndt/gfn519. Epub 2008 Sep 18. No abstract available.

PMID:
18802209
36.

Evaluation of parathyroid gland angiogenesis in chronic kidney disease associated with secondary hyperparathyroidism.

Martins P, Schmitt F, Almeida H, Frazão JM.

Nephrol Dial Transplant. 2008 Sep;23(9):2889-94. doi: 10.1093/ndt/gfn150. Epub 2008 Apr 8.

PMID:
18398016
37.

Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients.

Ferreira A, Frazão JM, Monier-Faugere MC, Gil C, Galvao J, Oliveira C, Baldaia J, Rodrigues I, Santos C, Ribeiro S, Hoenger RM, Duggal A, Malluche HH; Sevelamer Study Group.

J Am Soc Nephrol. 2008 Feb;19(2):405-12. doi: 10.1681/ASN.2006101089. Epub 2008 Jan 16.

38.

The OPTIMA study: assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidism.

Messa P, Macário F, Yaqoob M, Bouman K, Braun J, von Albertini B, Brink H, Maduell F, Graf H, Frazão JM, Bos WJ, Torregrosa V, Saha H, Reichel H, Wilkie M, Zani VJ, Molemans B, Carter D, Locatelli F.

Clin J Am Soc Nephrol. 2008 Jan;3(1):36-45. doi: 10.2215/CJN.03591006.

39.

Secondary hyperparathyroidism disease stabilization following calcimimetic therapy.

Frazão J, Rodriguez M.

NDT Plus. 2008 Jan;1(Suppl 1):i12-i17. doi: 10.1093/ndtplus/sfm039.

40.

Efficacy of the intralesional treatment with Chenopodium ambrosioides in the murine infection by Leishmania amazonensis.

Patrício FJ, Costa GC, Pereira PV, Aragão-Filho WC, Sousa SM, Frazão JB, Pereira WS, Maciel MC, Silva LA, Amaral FM, Rebêlo JM, Guerra RN, Ribeiro MN, Nascimento FR.

J Ethnopharmacol. 2008 Jan 17;115(2):313-9. Epub 2007 Oct 16.

PMID:
18035510
41.

Increase of cellular recruitment, phagocytosis ability and nitric oxide production induced by hydroalcoholic extract from Chenopodium ambrosioides leaves.

Cruz GV, Pereira PV, Patrício FJ, Costa GC, Sousa SM, Frazão JB, Aragão-Filho WC, Maciel MC, Silva LA, Amaral FM, Barroqueiro ES, Guerra RN, Nascimento FR.

J Ethnopharmacol. 2007 Apr 20;111(1):148-54. Epub 2006 Nov 10.

PMID:
17156956
42.

Calcimimetic agents: review and perspectives.

Ureña P, Frazão JM.

Kidney Int Suppl. 2003 Jun;(85):S91-6. Review.

PMID:
12753275
43.

The calcimimetic agents: perspectives for treatment.

Frazão JM, Martins P, Coburn JW.

Kidney Int Suppl. 2002 May;(80):149-54. Review.

44.

Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D(2)) in dialysis patients with secondary hyperparathyroidism: a sequential comparison.

Maung HM, Elangovan L, Frazão JM, Bower JD, Kelley BJ, Acchiardo SR, Rodriguez HJ, Norris KC, Sigala JF, Rutkowski M, Robertson JA, Goodman WG, Levine BS, Chesney RW, Mazess RB, Kyllo DM, Douglass LL, Bishop CW, Coburn JW.

Am J Kidney Dis. 2001 Mar;37(3):532-43.

PMID:
11228177
45.

Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidism.

Frazão JM, Elangovan L, Maung HM, Chesney RW, Acchiardo SR, Bower JD, Kelley BJ, Rodriguez HJ, Norris KC, Robertson JA, Levine BS, Goodman WG, Gentile D, Mazess RB, Kyllo DM, Douglass LL, Bishop CW, Coburn JW.

Am J Kidney Dis. 2000 Sep;36(3):550-61.

PMID:
10977787
46.

A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism.

Goodman WG, Frazao JM, Goodkin DA, Turner SA, Liu W, Coburn JW.

Kidney Int. 2000 Jul;58(1):436-45.

47.

Calcium-sensing receptor and calcimimetic agents.

Coburn JW, Elangovan L, Goodman WG, Frazaõ JM.

Kidney Int Suppl. 1999 Dec;73:S52-8. Review.

PMID:
10633465
48.

Epstein-Barr-virus-induced interstitial nephritis in an HIV-positive patient with progressive renal failure.

Frazão JM, Elangovan L, Felsenfeld AJ, Stanley TM, Cohen AH.

Nephrol Dial Transplant. 1998 Jul;13(7):1849-52. No abstract available.

PMID:
9681746
49.

Supplemental Content

Loading ...
Support Center